People · Operator
Named in public records as an officer, director or promoter · active 2009–2011 · Other, Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| TYRX, Inc. | — | Other | Series B | $40.7M | $33.2M | 2009 |
| Cenerx Biopharma Inc | — | Biotechnology | Series A | $33.3M | $186.3M | 2009 |
| Lead Therapeutics, Inc. | — | Biotechnology | Seed | $3.0M | $133.2M | 2009 |
Arthur Pappas at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Arthur Pappas on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Anthony Sun | 1 | 8 |
| TING PAU OEI | 1 | 7 |
| Scott Requadt | 1 | 5 |
| Steven Elms | 1 | 5 |
| Steve Elms | 1 | 4 |
| Alain Schreiber | 1 | 3 |
| William Edelman | 1 | 3 |
| Leonard Post | 1 | 3 |
| Robert S White | 1 | 3 |
| Arthur S. Pappas | 1 | 2 |
| Steven J. Elms | 1 | 2 |
| Shuang Qiao | 1 | 2 |
| JEFF LEIDEN | 1 | 2 |
| Charles Cahn | 1 | 1 |
| Arikha Moses | 1 | 1 |
| Barry J Brand | 1 | 1 |
| Arthur J Pappas | 1 | 1 |
| Mark J Baric | 1 | 1 |
| David Hanabusa | 1 | 1 |
| Peter Myers | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.